Aragen Bioscience, a fully owned subsidiary of GVK BIO and a large molecule CRO, and University of Technology Sydney (UTS), a university in Australia, have formed a collaboration to accelerate biologics R&D in Australia.
GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as the New Chief Commercial Officer of GVK BIO
BIO announced the launch of India’s first mobile App ‘eCule’ for drug discovery services. The App simplifies the whole ordering process from inquiry to delivery and also allows live tracking to stay apprised with the project.